A Phase I continuous infusion Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Remimazolam Besylate injection in Healthy Volunteers
Latest Information Update: 03 Jan 2020
At a glance
- Drugs Remimazolam (Primary) ; Midazolam
- Indications Anaesthesia; Sedation
- Focus Adverse reactions; Therapeutic Use
- 23 Dec 2019 Results evaluating the safety, pharmacokinetic (PK) and pharmacodynamic (PD) properties of remimazolam besylate following single ascending dose (SAD) and continuous infusion in healthy Chinese volunteers published in the European Journal of Clinical Pharmacology
- 21 Dec 2016 Status changed from recruiting to active, no longer recruiting,according to a PAION media release.
- 07 Oct 2016 New trial record